Valuation: Olympus Corporation

Market Cap 1,886B 11.68B 10.21B 9.42B 8.7B 16.51B 1,114B 16.79B 113B 44.2B 549B 43.84B 42.88B P/E 2027 *
19.5x
P/E 2028 * 16.2x
Enterprise Value 1,956B 12.11B 10.59B 9.77B 9.02B 17.12B 1,155B 17.41B 117B 45.84B 569B 45.46B 44.47B EV / Sales 2027 *
1.84x
EV / Sales 2028 * 1.75x
Free-Float
94.53%
Yield 2027 *
1.74%
Yield 2028 * 1.82%
1 day+1.25%
1 week+0.42%
Current month+4.50%
1 month+4.26%
3 months+13.20%
6 months-14.86%
Current year-10.53%
1 week 1,729.5
Extreme 1729.5
1,818
1 month 1,610
Extreme 1610
1,818
Current year 1,302.5
Extreme 1302.5
2,137
1 year 1,302.5
Extreme 1302.5
2,168
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%+0.42%+4.04%-19.44% 11.53B
+0.62%+2.50%+24.73%+0.74% 196B
+0.50%-5.20%-20.55%+18.26% 144B
+0.21%+3.18%+1.03%-16.34% 141B
-0.23%+0.34%-57.11%-15.23% 66.54B
-0.45%-3.32%+17.55%-1.15% 53.09B
+2.88%+2.15%-22.53%-30.41% 44.12B
-0.67%+2.20%+11.15%+11.83% 37.93B
-0.30%-0.72%+23.66%+39.70% 36.96B
+1.41%+1.22%-11.85%-19.37% 29.43B
Average +0.54%-0.76%-2.99%-3.14% 76.04B
Weighted average by Cap. +0.46%-0.83%-1.10%-1.08%

Financials

2027 *2028 *
Net sales 1,065B 6.59B 5.77B 5.32B 4.91B 9.32B 629B 9.48B 63.57B 24.96B 310B 24.76B 24.22B 1,107B 6.85B 5.99B 5.53B 5.1B 9.69B 653B 9.85B 66.04B 25.93B 322B 25.72B 25.16B
Net income 98.47B 610M 533M 492M 454M 862M 58.14B 876M 5.88B 2.31B 28.64B 2.29B 2.24B 118B 728M 637M 587M 542M 1.03B 69.41B 1.05B 7.02B 2.76B 34.2B 2.73B 2.67B
Net Debt 69.9B 433M 379M 349M 322M 612M 41.28B 622M 4.17B 1.64B 20.33B 1.62B 1.59B 51.9B 321M 281M 259M 239M 454M 30.65B 462M 3.1B 1.22B 15.1B 1.21B 1.18B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-07-13 ¥1,775.50 +1.25% 3,629,900
26-07-10 ¥1,753.50 +0.72% 3,945,500
26-07-09 ¥1,741.00 -1.64% 3,166,800
26-07-08 ¥1,770.00 -1.12% 4,558,100
26-07-07 ¥1,790.00 +1.47% 5,393,700
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,753.50JPY
Average target price
1,913.08JPY
Spread / Average Target
+9.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock